Partager

Essais des produits chimiques

Webinar Series on Testing and Assessment Methodologies

 

The OECD webinars on Testing and Assessment Methodologies focus on selected ongoing projects that will result in the short to medium term in new methodologies to test and assess chemicals. These free webinars are open to potential end users among regulators and contract research organisations who want to get familiar with new standards and approaches. Video recordings of our webinars are made available online afterwards.

SAVE THE DATE: WEBINAR on HOW TO ASSESS EXPOSURE TO NANOMATERIALS? The evaluation result of existing tools/models

 

Webinar: How to access exposure to nanomaterials? The evaluation result of existing tools/models

WHEN: 2 December 2021 at 14:00 -16:00 CET / 08:00 - 10:00 EST

The webinar will be held in English and Spanish.

With the dramatic increase of nano-enabled products entering the market every year, human and environmental exposures are inevitable, which raises concerns in terms of the health and safety of such emerging nanomaterials. Scientific knowledge to assess the exposure to nanomaterials continues to improve. As an example, new exposure tools and models for nanomaterials are being developed.

To further promote the development in this area, the OECD compiled an inventory of available models and tools for assessing occupational, consumer and environmental exposure to Nanomaterials. 54 tools and models were initially compiled and following in-depth analyses, 10 occupational, 7 consumer and 6 environmental tools/models were recommended or evaluated as suitable for assessing exposure to nanomaterials. The detailed information on the analyses and evaluations are provided in the reports accessible from the Series on Nanomaterials website (No. 98, 99, 100 and 101).

The OECD will be hosting a webinar on 2 December at 14:00 CET. Tune in to hear the researchers present the key findings of the reports.

 Speakers and presentations:

  • Occupational project: Carla Ribalta Carrasco, PhD (Danish National Research Center for Working Environment)
  • Consumer project: Mohammad Zein Aghaji, PhD (Health Canada)
  • Environmental project: Marc LaPointe, Mathieu Dextraze (Environment and Climate Change Canada)

REGISTER HERE.

 

watch the WEBINAR replay on the implementation of the defined approaches on skin sensitisation

 

‌Humans and the environment are exposed every day to chemicals. How do we make sure that these chemicals are safe?

Industry is required to test these chemicals to understand how they may affect people and the environment. In the past, these tests were most commonly carried out on animals. As scientific methods and tools progress, the use of animals to test a product designed for humans are becoming obsolete, in addition to being unethical. With new methods being developed, it is possible to perform these tests on human and animal cell cultures with equally rigorous and robust results. Because the OECD is committed to chemical safety and animal welfare, a new ground-breaking Guideline on Defined Approaches for Skin Sensitisation (OECD GL 497) was released on 14 June 2021. It is the first ever Guideline that uses non-animal methods to predict whether a chemical can cause skin allergies.

The OECD organised a webinar on 18 October 2021 to discuss the implementation of the Defined Approaches on Skin Sensitisation for chemical safety in member countries. This webinar paved the way for companies and authorities to determine the environmental toxicity of chemicals without having to resort to animal testing.

 

 Speakers and presentations

  • Anne Gourmelon: OECD Environment Directorate | Presentation
  • Nicole Kleinestreuer (NICEATM) and Silvia Casati (EURL ECVAM) | Presentation
  • Anna Lowit (US EPA OPP)
  • Paul Brown (US FDA) 
  • Laura Rossi (ECHA) | Presentation
  • Andre Muller (RIVM) | Presentation

Access the Question and Answers document here

 

MISSED OUR previous WEBINARS? WATCH THE VIDEO RECORDINGS

Webinar on Physiologically Based Kinetic (PBK) Models

10 May 2021: Gaining acceptance in next generation PBK modelling approaches for regulatory assessment

The OECD presented the recently published Guidance Document on the Characterisation, Validation and Reporting of Physiologically Based Kinetic (PBK) Models for Regulatory Purposes. This guidance aims to increase the confidence in the use of PBK models parameterised with data derived from in vitro and in silico methods, and help address “unfamiliar” uncertainties associated with these methods.

The webinar introduced the assessment framework for PBK models that was developed to evaluate the attributes and uncertainties of these models, including a dedicated discussion on sensitivity analysis. It also focused on the scientific workflow for characterising and validating PBK models together with a template for documenting PBK models in a systematic manner and a checklist to support model evaluation. Access the presentation here.

 

Webinars on Adverse Outcome Pathways (AOPs) 

30 November 2020: Training needs, resources, and opportunities for Adverse Outcome Pathways (AOPs) | Presentations:

  • Introduction by Magdalini Sachana and Mirjam Luijten | Presentation
  • From Data to Knowledge and Beyond AOPs as common interface by Brigitte Landesmann | Presentation
  • OECD Programme on Adverse Outcome Pathways (AOPs) by Bette Meek | Presentation
  • Concluding remarks by Mirjam Luijten | Presentation

30 January 2020: AOP knowledge base and AOP developing tips | Presentations:

  • Nathalie Delrue from the OECD Environment Directorate introduced the presenters and scope of the webinar | Presentation
  • Clemens Wittwehr from the European Commission Joint Research Centre provided an introduction on AOP-KB | Presentation
  • Dan Villeneuve from the US Environmental Protection Agency provided some tips on the development of AOPs | Presentation
  • Holly Mortensen from the US Environmental Protection Agency presented ways of retrieving information from databases and other AOP tools | Presentation

15 January 2020: Assembling and evaluating weight of evidence and quantitative understanding | Presentations

  • Magda Sachana from the OECD Environment Directorate introduced the presenters and scope of the webinar | Presentation
  • Bette Meek from the University of Ottawa provided an introduction to WoE for AOPs | Presentation
  • Kristie Sullivan from the Physicians Committee for Responsible Medicine shared examples of implementing WoE in an AOP | Presentation
  • Dan Villeneuve from the US Environmental Protection Agency spoke about quantitative understanding of relationships and why that’s important | Presentation.

30 April 2019: Adverse Outcome Pathway (AOP) framework | Presentations: 

  • Nathalie Delrue (OECD Secretariat): OECD AOP Programme | Presentation
  • Catherine Willett (Humane Society International): An Introduction to AOP framework | Presentation
  • Jason O’Brien (Environment Canada): AOP collaborative development | Presentation
  • Dan Villeneuve (US Environmental Protection Agency): Examples of AOP application in chemical risk assessment | Presentation 

 

Webinars on Testing and Assessment Methodologies:

27 September 2019: OECD Alternatives to in vivo eye irritation testing

  • Chantra Eskes (Swiss 3Rs Competence Centre): Available test methods and IATA Guidance Document 263 | Presentation
  • Dave Allen (Integrated Laboratory Systems): Alternatives for eye irritation testing: usefulness and limitations | Presentation
  • Bertrand Desprez (Cosmetics Europe): Two defined approaches for ocular toxicity predictions | Presentation

16 January 2019: Defined Approaches for Skin Sensitisation

 

Webinars on Nanomaterials:

25 February 2021: Assessing the dispersion stability and dissolution rate of nanomaterials in the environment

The recording is available in Spanish / El video está disponible en español.

26 January 2021: Guidance document No. 317 on aquatic & sediment ecotoxicity testing of nanomaterials

The recording is available in Spanish / El video está disponible en español.

ENGAGE WITH US

 

Documents connexes

 

Also AvailableEgalement disponible(s)